PACAP-38 in Acute ST-Segment Elevation Myocardial Infarction in Humans and Pigs: A Translational Study

Autor: Zsolt Sarszegi, Attila Gyenesei, Péter Ferdinandy, Ádám Németh, Anikó Görbe, Attila Cziráki, Andrea Tamas, András Makkos, Róbert Herczeg, Zsuzsanna Helyes, Beata Polgar, Éva Sághy, Dora Reglodi, Dóra Szabó
Rok vydání: 2021
Předmět:
Male
Swine
medicine.medical_treatment
Myocardial Infarction
030204 cardiovascular system & hematology
lcsh:Chemistry
0302 clinical medicine
Risk Factors
Myocardial infarction
Non-ST Elevated Myocardial Infarction
prognostic factor
Receptor
lcsh:QH301-705.5
pituitary adenylate cyclase activating polypeptide
Spectroscopy
Cardioprotection
biology
General Medicine
Middle Aged
Troponin
Computer Science Applications
Treatment Outcome
medicine.anatomical_structure
cardioprotection
Cardiology
Pituitary Adenylate Cyclase-Activating Polypeptide
Female
ELISA
hormones
hormone substitutes
and hormone antagonists

endocrine system
medicine.medical_specialty
Heart Ventricles
acute myocardial infarction
closed-chest myocardial infarction model
Neuropeptide
Article
Catalysis
STEMI
Inorganic Chemistry
03 medical and health sciences
Percutaneous Coronary Intervention
Internal medicine
medicine
Animals
Humans
cardiovascular diseases
Physical and Theoretical Chemistry
Molecular Biology
Aged
Glycated Hemoglobin
business.industry
Organic Chemistry
Percutaneous coronary intervention
Arrhythmias
Cardiac

medicine.disease
lcsh:Biology (General)
lcsh:QD1-999
Ventricle
Conventional PCI
biology.protein
ST Elevation Myocardial Infarction
business
030217 neurology & neurosurgery
Zdroj: International Journal of Molecular Sciences, Vol 22, Iss 2883, p 2883 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 6
ISSN: 1422-0067
Popis: Acute myocardial infarction (MI) is one of the most common causes of death worldwide. Pituitary adenylate cyclase activating polypeptide (PACAP) is a cardioprotective neuropeptide expressing its receptors in the cardiovascular system. The aim of our study was to examine tissue PACAP-38 in a translational porcine MI model and plasma PACAP-38 levels in patients with ST-segment elevation myocardial infarction (STEMI). Significantly lower PACAP-38 levels were detected in the non-ischemic region of the left ventricle (LV) in MI heart compared to the ischemic region of MI-LV and also to the Sham-operated LV in porcine MI model. In STEMI patients, plasma PACAP-38 level was significantly higher before percutaneous coronary intervention (PCI) compared to controls, and decreased after PCI. Significant negative correlation was found between plasma PACAP-38 and troponin levels. Furthermore, a significant effect was revealed between plasma PACAP-38, hypertension and HbA1c levels. This was the first study showing significant changes in cardiac tissue PACAP levels in a porcine MI model and plasma PACAP levels in STEMI patients. These results suggest that PACAP, due to its cardioprotective effects, may play a regulatory role in MI and could be a potential biomarker or drug target in MI.
Databáze: OpenAIRE